Editorial
Hypertrophic Cardiomyopathy in the Genomic Era
JACC: Heart Failure · 2026-08 · 14 (8) · 103177
DOI: 10.1016/j.jchf.2026.103177 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Heart Failure, 2026-08. Verfasst von Alessia Argirò und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy. Electronic address: argiro.alessia@gmail.com. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
genetic testinghypertrophic cardiomyopathyrisk stratification
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy. Electronic address: argiro.alessia@gmail.com.
- Division of Cardiovascular Medicine, Department of Medicine, University of California-San Diego, La Jolla, California, USA.
Zitieren
APA
Argirò, A., & Bui, Q. M. (2026). Hypertrophic Cardiomyopathy in the Genomic Era. JACC: Heart Failure, 14(8), 103177. https://doi.org/10.1016/j.jchf.2026.103177
Vancouver
Argirò A, Bui QM. Hypertrophic Cardiomyopathy in the Genomic Era. JACC: Heart Failure. 2026;14(8):103177. doi:10.1016/j.jchf.2026.103177
BibTeX
@article{Argir2026,
author = {Argirò, Alessia and Bui, Quan M},
title = {Hypertrophic Cardiomyopathy in the Genomic Era},
journal = {JACC: Heart Failure},
year = {2026},
volume = {14},
number = {8},
pages = {103177},
doi = {10.1016/j.jchf.2026.103177}
}
EUVIMED